Co-formulation and co-delivery of ionizable colloid forming drugs with nucleic acids
AssigneeThe Governing Council of the University of Toronto
InventorsKai Vincent Slaughter, Molly Sandra Shoichet, Eric Niel Rummens Donders
Life of this patent
Estimating the term…
Abstract
A co-formulation comprising: (i) an ionizable colloid forming active substance; (ii) a nucleic acid molecule; and (iii) an amphiphilic molecule. Also, a method of treating a disease or disorder comprising administering the co-formulation to a subject in need, wherein the ionizable colloid-forming active substance and the nucleic acid molecule included in the co-formulation act together in the treatment of the disease or disorder; and a method of manufacturing the co-formulation.
Claims27
A co-formulation comprising:
- (i) an ionizable colloid forming active substance;
- (ii) a nucleic acid molecule;
- and
- (iii) an amphiphilic molecule.
An ionizable analog of emetine comprising emetine modified to include a hydrophobic group.
Dependencies are inferred from the claim text.